On the other hand, our analysis identified ITGB1, ITGA5, and ITGA6 as key integrins significantly associated with poor prognosis in HNSC, underscoring their role in driving tumor aggressiveness and therapeutic resistance. The gene discussed is ITGA6; the disease is neoplasm.